Drug Topics CPE accreditor begins 3-year service to AACP
July 20th 2012During the American Association of Colleges of Pharmacy (AACP) Annual Meeting in Kissimmee, Fla. in mid-July, Jill Fitzgerald, PharmD, who is Drug Topics CPE accreditor, was sworn in as chair-elect to the AACP Continuing Professional Education Section.
FDA approves REMS for ER, long-acting opioids
July 17th 2012FDA has approved a new risk evaluation and mitigation strategy for extended-release and long-acting opioids that requires that healthcare professionals are educated on how to safely prescribe the drugs and that patients understand how to safely use the drugs.
FDA approves once-daily oral agent for HIV prevention in uninfected adults
July 17th 2012FDA has approved once-daily oral emtricitabine and tenofovir disoproxil fumarate (Truvada, Gilead Sciences), in combination with safer sex practices, to reduce the risk of sexually acquired HIV-1 infection in adults at high risk.
FDA: Single IV dose of ondansetron may cause potentially fatal heart rhythms
July 12th 2012FDA is alerting healthcare professionals to the possibility that a 32-mg single intravenous dose of ondansetron (Zofran, ondansetron hydrochloride, and generics) could lead to QT interval prolongation, putting patients at risk for a potentially fatal heart rhythm known as Torsades de Pointes.